LB Pharmaceuticals, Inc. (LBRX)

48.80 +0.59 (+1.22%) USD  |  NASDAQ  |  Aug 25, 16:00
48.78 -0.02 (-0.04%) After-Hours: 19:59
More

LB Pharmaceuticals EV to CFO

EV to CFO Chart

View EV to CFO for LBRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to CFO Chart
Start Trial

Historical EV to CFO Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
Date Value
December 31, 2025 --
September 30, 2025 --

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
Ligand Pharmaceuticals, Inc. Upgrade
Neumora Therapeutics, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade

EV to CFO Related Metrics

EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade